InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: north40000 post# 264760

Monday, 05/23/2016 10:48:07 PM

Monday, May 23, 2016 10:48:07 PM

Post# of 345732
I only mentioned since it seems at the flipped PS surface, that AZ is the closest to Peregrine at the time...and maybe all options are still open and I only thought of JnJ and AstraZeneca, because if AZ seals the deal completely with PS Targeting/Peregrine....

then maybe JnJ goes after AZ


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News